Impax Asset Management Group Share Forecast, Price & News

Impax Asset Management Group (LON:IPX) Frequently Asked Questions

Is Impax Asset Management Group a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Impax Asset Management Group in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Impax Asset Management Group stock.
View analyst ratings for Impax Asset Management Group or view top-rated stocks.

How has Impax Asset Management Group's stock been impacted by COVID-19?

Impax Asset Management Group's stock was trading at GBX 320 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IPX stock has increased by 259.4% and is now trading at GBX 1,150.
View which stocks have been most impacted by COVID-19.

How often does Impax Asset Management Group pay dividends? What is the dividend yield for Impax Asset Management Group?

Impax Asset Management Group declared a dividend on Thursday, December 2nd. Investors of record on Thursday, February 10th will be given a dividend of GBX 17 per share on Thursday, March 31st. This represents a dividend yield of 1.26%. The ex-dividend date of this dividend is Thursday, February 10th. This is a boost from Impax Asset Management Group's previous dividend of GBX 3.60. The official announcement can be viewed at this link.
View Impax Asset Management Group's dividend history.

Is Impax Asset Management Group a good dividend stock?

Impax Asset Management Group pays an annual dividend of GBX 0.10 per share and currently has a dividend yield of 1.75%. The dividend payout ratio of Impax Asset Management Group is 0.34%. This payout ratio is at a healthy, sustainable level, below 75%.
View Impax Asset Management Group's dividend history.

What price target have analysts set for IPX?

3 Wall Street analysts have issued twelve-month price objectives for Impax Asset Management Group's stock. Their forecasts range from GBX 1,180 to GBX 1,550. On average, they anticipate Impax Asset Management Group's stock price to reach GBX 1,303.33 in the next year. This suggests a possible upside of 13.3% from the stock's current price.
View analysts' price targets for Impax Asset Management Group or view top-rated stocks among Wall Street analysts.

Who are Impax Asset Management Group's key executives?

Impax Asset Management Group's management team includes the following people:

• Mr. Ian Richard Simm, Founder, Chief Exec., MD & Exec. Director (Age 54, Pay $1.41M)
• Mr. Charles D. Ridge, Exec. Director & CFO (Age 57)
• Mr. Zack Wilson, Exec. Director, Group Gen. Counsel & Company Sec.
• Paul French, Corp. Communications Director
• Ms. Meg Brown, Exec. Director of Marketing & Bus. Devel.
• Ms. Fiona Anderson, Exec. Director & Global Head of HR
• Mr. Bruce Jenkyn-Jones, Exec. Director & Co-Head of Listed Equities business (Age 55)
• Mr. Peter Van Egmond Rossbach, Managing Director of Private Equity Infrastructure (Age 62)
• Mr. Hubert Aarts, Exec. Director & Co-Head of the Listed Equity business (Age 50)
• Mr. Jonathan Michael Forster, MD & Sr. Portfolio Mang. (Age 50)

Who are some of Impax Asset Management Group's key competitors?

Some companies that are related to Impax Asset Management Group include M&G (MNG), Intermediate Capital Group (ICP), Pershing Square (PSH), CI Financial (CIX), Brookfield Infrastructure (BIPC), Norbord (OSB), F&C Investment Trust (FCIT), RIT Capital Partners (RCP), HICL Infrastructure (HICL), Greencoat UK Wind (UKW), Old Mutual (OMU), 3i Infrastructure (3IN), Alliance Trust (ATST), The Renewables Infrastructure Group (TRIG) and Smithson Investment Trust (SSON).
View all of IPX's competitors.

What other stocks do shareholders of Impax Asset Management Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Impax Asset Management Group investors own include Corbus Pharmaceuticals (CRBP), Legal & General Group (LGEN), DS Smith (SMDS), Victrex (VCT), Andlauer Healthcare Group (AND), Alnylam Pharmaceuticals (ALNY), Ashtead Group (AHT), Agenus (AGEN), Affimed (AFMD) and AerCap (AER).

What is Impax Asset Management Group's stock symbol?

Impax Asset Management Group trades on the London Stock Exchange (LON) under the ticker symbol "IPX."

How do I buy shares of Impax Asset Management Group?

Shares of IPX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Impax Asset Management Group's stock price today?

One share of IPX stock can currently be purchased for approximately GBX 1,150.

How much money does Impax Asset Management Group make?

Impax Asset Management Group has a market capitalization of £1.52 billion and generates £143.06 million in revenue each year.

How many employees does Impax Asset Management Group have?

Impax Asset Management Group employs 190 workers across the globe.

What is Impax Asset Management Group's official website?

The official website for Impax Asset Management Group is www.impaxam.com.

Where are Impax Asset Management Group's headquarters?

Impax Asset Management Group is headquartered at Norfolk House, 31 St. James's Square, LONDON, SW1Y 4JR, United Kingdom.

How can I contact Impax Asset Management Group?

Impax Asset Management Group's mailing address is Norfolk House, 31 St. James's Square, LONDON, SW1Y 4JR, United Kingdom. The company can be reached via phone at +44-20-74341122.